A cellular fluorescence endpoint is not a patient seizure-control rate.
What the paper found
The SH-SY5Y model compared diazepam, low-frequency stimulation and their combination. The combined condition had the lowest calcium-related fluorescence change, with differences from the individual conditions. The authors interpreted this as reduced excitability in their experimental model.
Limits of the evidence
A cell-line system does not reproduce an intact brain, seizure network or clinical stimulation procedure. Fluorescence is a proxy with assay-specific meaning. An apparent combination advantage does not independently establish clinical synergy or long-term safety.
Implications for case review
Name the cell model and measured signal before describing an antiseizure benefit. The finding cannot support a human dosing or stimulation protocol, or establish why an individual patient responded to treatment. It provides a mechanistic research hypothesis rather than a demonstrated clinical outcome.
Source and related reading
Source: PMC12383370, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Noni Extract and Diazepam in Mice: Reduced Movement Is a Limited Sedation Endpoint.
Leave a Reply